Cleveland Clinic researchers are working on a mechanism-guided therapy that would use stem cells to treat patients with complex regional pain syndrome.
Read MoreCan Stem Cells ‘Stem’ the Use of Opioids? Study Shows Great Promise
Addressing the challenge of opioid tolerance and overdose, Cleveland Clinic research finds new treatment option may improve opioid therapy.
Novel Treatment Modality May Ease Painful Diabetic Neuropathy
High-frequency spinal cord stimulation is being studied as a treatment option for people suffering from painful peripheral diabetic neuropathy.
Pain and Wellness: How They’re Connected
Patients can do more to minimize pain on their own by maximizing their wellness. Help them understand how four lifestyle factors — sleep, movement, stress management and diet — can control pain naturally.
Genetics and Pain: Optimizing Gene Expression and the Potential of Pharmacogenetics
Knowing how patients metabolize medication could be a powerful tool for doctors seeking the right pain remedies for patients. Pharmacogenomics is a growing industry and one that needs further research to be useful says a Cleveland Clinic pain specialist.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Stem Cell Therapy for Neuropathic Pain: New Findings Show Promise
Studies at Cleveland Clinic have demonstrated the effectiveness of mesenchymal stem cell (MSC) transplantation in reducing hyperalgesia caused by nerve injury. Jianguo Cheng, MD, PhD, talks about findings from animal studies.
Women and Pain: What New Research Reveals
New research reveals more about how women experience pain differently than men. See what recent reports say about gender differences in headache and musculoskeletal, abdominal and pelvic pain.
A Closer Look at Three Promising Research Projects by Cleveland Clinic Pain Specialists
Cleveland Clinic pain management specialists are researching innovative ways to ease TMJ, lower extremity and diskogenic back pain. Initial successes show promise for patients with refractory conditions.